The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ps.40.1.80

Our study shows that increased length of stay is associated with the presence of psychiatric comorbidity in inpatients who have certain medical illnesses such as neoplasms; circulatory, digestive, renal, and respiratory disorders; and operative procedures. Our resuits suggest that the effects of psychiatric interventions for such patients should be explored and that studies of the cost-effectiveness of psychiatric interventions should be focused on categories of medical illness in which psychiatric comorbidity is associated with increased length of stay.

Collaboration between researchers in medicine and psychiatry is an important approach to containing the cost of hospital care, and by furthering the recognition and treatment of psychiatric comorbidities, such collaboration can also enhance patient's health.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.